{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:05:02Z","timestamp":1768734302096,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"DST-SERB","award":["EMR\/2015\/000761"],"award-info":[{"award-number":["EMR\/2015\/000761"]}]},{"name":"DST-SERB","award":["EEQ\/2017\/000794"],"award-info":[{"award-number":["EEQ\/2017\/000794"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-022-02889-6","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T14:02:48Z","timestamp":1659708168000},"page":"2351-2365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues"],"prefix":"10.1007","volume":"24","author":[{"given":"Vikrant","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhat","family":"Suman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-8613","authenticated-orcid":false,"given":"Harish","family":"Chander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"2889_CR1","doi-asserted-by":"publisher","unstructured":"T Avril E Vauleon E Chevet 2017 Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers Oncogenesis 6 8 e373 https:\/\/doi.org\/10.1038\/oncsis.2017.72","DOI":"10.1038\/oncsis.2017.72"},{"issue":"5","key":"2889_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccr.2014.03.015","volume":"25","author":"HJ Clarke","year":"2014","unstructured":"Clarke HJ, Chambers JE, Liniker E, Marciniak SJ. Endoplasmic reticulum stress in malignancy. Cancer Cell. 2014;25(5):563\u201373. https:\/\/doi.org\/10.1016\/j.ccr.2014.03.015.","journal-title":"Cancer Cell"},{"issue":"1","key":"2889_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/boc.201800050","volume":"111","author":"E Madden","year":"2019","unstructured":"Madden E, Logue SE, Healy SJ, Manie S, Samali A. The role of the unfolded protein response in cancer progression: from oncogenesis to chemoresistance. Biol Cell. 2019;111(1):1\u201317. https:\/\/doi.org\/10.1111\/boc.201800050.","journal-title":"Biol Cell"},{"issue":"6","key":"2889_CR4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1158\/2159-8290.CD-14-1490","volume":"5","author":"E Chevet","year":"2015","unstructured":"Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress\u2013activated cell reprogramming in oncogenesis. Cancer Discov. 2015;5(6):586\u201397. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-1490.","journal-title":"Cancer Discov"},{"issue":"10","key":"2889_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/cancers10100344","volume":"10","author":"EP McGrath","year":"2018","unstructured":"McGrath EP, Logue SE, Mnich K, Deegan S, J\u00e4ger R, Gorman AM, et al. The unfolded protein response in breast cancer. Cancers. 2018;10(10):344. https:\/\/doi.org\/10.3390\/cancers10100344.","journal-title":"Cancers"},{"issue":"1","key":"2889_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4049\/jimmunol.182.1.466","volume":"182","author":"IN Mungrue","year":"2009","unstructured":"Mungrue IN, Pagnon J, Kohannim O, Gargalovic PS, Lusis AJ. CHAC1\/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade. J Immunol. 2009;182(1):466\u201376. https:\/\/doi.org\/10.4049\/jimmunol.182.1.466.","journal-title":"J Immunol"},{"issue":"12","key":"2889_CR7","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/embor.2012.156","volume":"13","author":"A Kumar","year":"2012","unstructured":"Kumar A, Tikoo S, Maity S, Sengupta S, Sengupta S, Kaur A, et al. Mammalian proapoptotic factor ChaC1 and its homologues function as \u03b3-glutamyl cyclotransferases acting specifically on glutathione. EMBO Rep. 2012;13(12):1095\u2013101. https:\/\/doi.org\/10.1038\/embor.2012.156.","journal-title":"EMBO Rep"},{"issue":"34","key":"2889_CR8","doi-asserted-by":"publisher","first-page":"12741","DOI":"10.1073\/pnas.0605457103","volume":"103","author":"PS Gargalovic","year":"2006","unstructured":"Gargalovic PS, Imura M, Zhang B, Gharavi NM, Clark MJ, Pagnon J, et al. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci. 2006;103(34):12741\u20136. https:\/\/doi.org\/10.1073\/pnas.0605457103.","journal-title":"Proc Natl Acad Sci"},{"key":"2889_CR9","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.3389\/fimmu.2018.02823","volume":"9","author":"L Perra","year":"2018","unstructured":"Perra L, Balloy V, Foussigni\u00e8re T, Moissenet D, Petat H, Mungrue IN, et al. CHAC1 is differentially expressed in normal and cystic fibrosis bronchial epithelial cells and regulates the inflammatory response induced by Pseudomonas aeruginosa. Front Immunol. 2018;9:2823. https:\/\/doi.org\/10.3389\/fimmu.2018.02823.","journal-title":"Front Immunol"},{"key":"2889_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118347","volume":"261","author":"S Li","year":"2020","unstructured":"Li S, Jia Y, Xue M, Hu F, Zheng Z, Zhang S, et al. Inhibiting Rab27a in renal tubular epithelial cells attenuates the inflammation of diabetic kidney disease through the miR-26a-5p\/CHAC1\/NF-kB pathway. Life Sci. 2020;261: 118347. https:\/\/doi.org\/10.1016\/j.lfs.2020.118347.","journal-title":"Life Sci"},{"issue":"70","key":"2889_CR11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23055","volume":"8","author":"M-S Chen","year":"2017","unstructured":"Chen M-S, Wang S-F, Hsu C-Y, Yin P-H, Yeh T-S, Lee H-C, et al. CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2\u03b1-ATF4 pathway. Oncotarget. 2017;8(70): 114588. https:\/\/doi.org\/10.18632\/oncotarget.23055.","journal-title":"Oncotarget"},{"issue":"3","key":"2889_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbrc.2019.09.023","volume":"519","author":"N Wang","year":"2019","unstructured":"Wang N, Zeng G-Z, Yin J-L, Bian Z-X. Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt\u2019s Lymphoma. Biochem Biophys Res Commun. 2019;519(3):533\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.023.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2889_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12598","volume":"24","author":"T Ogawa","year":"2019","unstructured":"Ogawa T, Wada Y, Takemura K, Board PG, Uchida K, Kitagaki K, et al. CHAC1 overexpression in human gastric parietal cells with Helicobacter pylori infection in the secretory canaliculi. Helicobacter. 2019;24(4): e12598. https:\/\/doi.org\/10.1111\/hel.12598.","journal-title":"Helicobacter"},{"issue":"4","key":"2889_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/2211-5463.12402","volume":"8","author":"Y Wada","year":"2018","unstructured":"Wada Y, Takemura K, Tummala P, Uchida K, Kitagaki K, Furukawa A, et al. Helicobacter pylori induces somatic mutations in TP 53 via overexpression of CHAC 1 in infected gastric epithelial cells. FEBS Open Bio. 2018;8(4):671\u20139. https:\/\/doi.org\/10.1002\/2211-5463.12402.","journal-title":"FEBS Open Bio"},{"issue":"12","key":"2889_CR15","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1007\/s10792-019-01129-1","volume":"39","author":"Y Liu","year":"2019","unstructured":"Liu Y, Li M, Shi D, Zhu Y. Higher expression of cation transport regulator-like protein 1 (CHAC1) predicts of poor outcomes in uveal melanoma (UM) patients. Int Opthalmol. 2019;39(12):2825\u201332. https:\/\/doi.org\/10.1007\/s10792-019-01129-1.","journal-title":"Int Opthalmol"},{"issue":"6","key":"2889_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nsmb.2050","volume":"18","author":"Y Stelzer","year":"2011","unstructured":"Stelzer Y, Yanuka O, Benvenisty N. Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells. Nat Struct Biol. 2011;18(6):735. https:\/\/doi.org\/10.1038\/nsmb.2050.","journal-title":"Nat Struct Biol"},{"issue":"7494","key":"2889_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature13119","volume":"508","author":"X Chen","year":"2014","unstructured":"Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1\u03b1 pathway. Nature. 2014;508(7494):103\u20137. https:\/\/doi.org\/10.1038\/nature13119.","journal-title":"Nature"},{"issue":"12","key":"2889_CR18","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.4155\/FMC.15.80","volume":"7","author":"KL Cook","year":"2015","unstructured":"Cook KL, Clarke R. Role of GRP78 in promoting therapeutic-resistant breast cancer. Future Med Chem. 2015;7(12):1529\u201334. https:\/\/doi.org\/10.4155\/FMC.15.80.","journal-title":"Future Med Chem"},{"issue":"1","key":"2889_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/bjc.2011.510","volume":"106","author":"G Goebel","year":"2012","unstructured":"Goebel G, Berger R, Strasak A, Egle D, M\u00fcller-Holzner E, Schmidt S, et al. Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients. Br J Cancer. 2012;106(1):189\u201398. https:\/\/doi.org\/10.1038\/bjc.2011.510.","journal-title":"Br J Cancer"},{"issue":"7","key":"2889_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2217\/cer-2017-0015","volume":"6","author":"B Jahn","year":"2017","unstructured":"Jahn B, Arvandi M, Rochau U, Fiegl H, Goebel G, Marth C, et al. Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1. J Comp Eff Res. 2017;6(7):563\u201374. https:\/\/doi.org\/10.2217\/cer-2017-0015.","journal-title":"J Comp Eff Res"},{"issue":"25","key":"2889_CR21","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1038\/onc.2012.317","volume":"32","author":"H Chander","year":"2013","unstructured":"Chander H, Truesdell P, Meens J, Craig AW. Transducer of Cdc42-dependent actin assembly promotes breast cancer invasion and metastasis. Oncogene. 2013;32(25):3080\u201390. https:\/\/doi.org\/10.1038\/onc.2012.317.","journal-title":"Oncogene"},{"issue":"5","key":"2889_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/carcin\/bgac015","volume":"43","author":"P Suman","year":"2022","unstructured":"Suman P, Mehta V, Craig AW, Chander H. Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion. Carcinogenesis. 2022;43(5):494\u2013503. https:\/\/doi.org\/10.1093\/carcin\/bgac015.","journal-title":"Carcinogenesis"},{"issue":"1","key":"2889_CR23","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5.","journal-title":"Sci Rep"},{"issue":"7783","key":"2889_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575(7783):512\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1631-3.","journal-title":"Nature"},{"issue":"3","key":"2889_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gy\u00f6rffy","year":"2010","unstructured":"Gy\u00f6rffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725\u201331. https:\/\/doi.org\/10.1007\/s10549-009-0674-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2889_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.ajpath.2013.08.002","volume":"183","author":"AG Rivenbark","year":"2013","unstructured":"Rivenbark AG, O\u2019Connor SM, Coleman WB. Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine. Am J Pathol. 2013;183(4):1113\u201324. https:\/\/doi.org\/10.1016\/j.ajpath.2013.08.002.","journal-title":"Am J Pathol"},{"issue":"1","key":"2889_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-018-0797-x","volume":"17","author":"R Butti","year":"2018","unstructured":"Butti R, Das S, Gunasekaran VP, Yadav AS, Kumar D, Kundu GC. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Mol Cancer. 2018;17(1):34. https:\/\/doi.org\/10.1186\/s12943-018-0797-x.","journal-title":"Mol Cancer"},{"issue":"1","key":"2889_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","volume":"17","author":"Z Du","year":"2018","unstructured":"Du Z, Lovly CM. Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer. 2018;17(1):58. https:\/\/doi.org\/10.1186\/s12943-018-0782-4.","journal-title":"Mol Cancer"},{"issue":"3","key":"2889_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/modpathol.2014.163","volume":"28","author":"B Weigelt","year":"2015","unstructured":"Weigelt B, Ng CK, Shen R, Popova T, Schizas M, Natrajan R, et al. Metastatic breast carcinomas display genomic and transcriptomic heterogeneity. Mod Pathol. 2015;28(3):340\u201351. https:\/\/doi.org\/10.1038\/modpathol.2014.163.","journal-title":"Mod Pathol"},{"issue":"8","key":"2889_CR30","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s12094-021-02552-6","volume":"23","author":"V Mehta","year":"2021","unstructured":"Mehta V, Chander H, Munshi A. Complex roles of discoidin domain receptor tyrosine kinases in cancer. Clin TranslOncol. 2021;23(8):1497\u20131510. https:\/\/doi.org\/10.1007\/s12094-021-02552-6.","journal-title":"Clin TranslOncol."},{"key":"2889_CR31","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","volume":"24","author":"A Prat","year":"2015","unstructured":"Prat A, Pineda E, Adamo B, Galv\u00e1n P, Fern\u00e1ndez A, Gaba L, et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. The Breast. 2015;24:S26\u201335. https:\/\/doi.org\/10.1016\/j.breast.2015.07.008.","journal-title":"The Breast"},{"issue":"10","key":"2889_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MC Cheang","year":"2009","unstructured":"Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101(10):736\u201350. https:\/\/doi.org\/10.1093\/jnci\/djp082.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2889_CR33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/modpathol.2013.153","volume":"27","author":"LP Feeley","year":"2014","unstructured":"Feeley LP, Mulligan AM, Pinnaduwage D, Bull SB, Andrulis IL. Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information. Mod Pathol. 2014;27(4):554\u201361. https:\/\/doi.org\/10.1038\/modpathol.2013.153.","journal-title":"Mod Pathol"},{"issue":"10","key":"2889_CR34","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/sj.bjc.6603756","volume":"96","author":"E De Azambuja","year":"2007","unstructured":"De Azambuja E, Cardoso F, de Castro G, Colozza M, Mano MS, Durbecq V, et al. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients. Br J Cancer. 2007;96(10):1504\u201313. https:\/\/doi.org\/10.1038\/sj.bjc.6603756.","journal-title":"Br J Cancer"},{"issue":"1","key":"2889_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4653-x","volume":"12","author":"AA Hashmi","year":"2019","unstructured":"Hashmi AA, Hashmi KA, Irfan M, Khan SM, Edhi MM, Ali JP, et al. Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters. BMC Res Notes. 2019;12(1):1\u20135. https:\/\/doi.org\/10.1186\/s13104-019-4653-x.","journal-title":"BMC Res Notes"},{"issue":"2","key":"2889_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","volume":"11","author":"R Yerushalmi","year":"2010","unstructured":"Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11(2):174\u201383. https:\/\/doi.org\/10.1016\/S1470-2045(09)70262-1.","journal-title":"Lancet Oncol"},{"key":"2889_CR37","doi-asserted-by":"publisher","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1-pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","DOI":"10.1126\/scisignal.2004088"},{"key":"2889_CR38","doi-asserted-by":"crossref","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. AACR; 2012.","DOI":"10.1158\/2159-8290.CD-12-0095"},{"issue":"1","key":"2889_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/ijms18010051","volume":"18","author":"R-C Ji","year":"2017","unstructured":"Ji R-C. Lymph nodes and cancer metastasis: new perspectives on the role of intranodal lymphatic sinuses. Int J Mol Sci. 2017;18(1):51. https:\/\/doi.org\/10.3390\/ijms18010051.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2889_CR40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc863","volume":"2","author":"SA Stacker","year":"2002","unstructured":"Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2(8):573\u201383. https:\/\/doi.org\/10.1038\/nrc863.","journal-title":"Nat Rev Cancer"},{"key":"2889_CR41","doi-asserted-by":"publisher","unstructured":"Mehta V, Meena J, Kasana H, Munshi A, Chander H. Prognostic significance of CHAC1 expression in breast cancer. Mol Biol Rep. 2022:1\u201310. doi:https:\/\/doi.org\/10.1007\/s11033-022-07673-x","DOI":"10.1007\/s11033-022-07673-x"},{"issue":"10","key":"2889_CR42","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1172\/JCI57088","volume":"121","author":"HG Russnes","year":"2011","unstructured":"Russnes HG, Navin N, Hicks J, Borresen-Dale A-L. Insight into the heterogeneity of breast cancer through next-generation sequencing. J Clin Invest. 2011;121(10):3810\u20138. https:\/\/doi.org\/10.1172\/JCI57088.","journal-title":"J Clin Invest"},{"key":"2889_CR43","doi-asserted-by":"crossref","unstructured":"Kalinowski L, Saunus JM, Reed AEM, Lakhani SR. Breast Cancer Heterogeneity in Primary and Metastatic Disease. Breast Cancer Metastasis and Drug Resistance. Springer; 2019. p. 75\u2013104.","DOI":"10.1007\/978-3-030-20301-6_6"},{"issue":"1","key":"2889_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41416-020-01161-4","volume":"124","author":"AI Riggio","year":"2020","unstructured":"Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2020;124(1):1\u201314. https:\/\/doi.org\/10.1038\/s41416-020-01161-4.","journal-title":"Br J Cancer"},{"key":"2889_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fmed.2017.00227","volume":"4","author":"G Turashvili","year":"2017","unstructured":"Turashvili G, Brogi E. Tumor heterogeneity in breast cancer. Front Med. 2017;4:227. https:\/\/doi.org\/10.3389\/fmed.2017.00227.","journal-title":"Front Med"},{"issue":"1","key":"2889_CR46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2009.12.007","volume":"140","author":"S Pece","year":"2010","unstructured":"Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 2010;140(1):62\u201373. https:\/\/doi.org\/10.1016\/j.cell.2009.12.007.","journal-title":"Cell"},{"issue":"12","key":"2889_CR47","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1016\/j.cellsig.2014.07.034","volume":"26","author":"AHN Kamdje","year":"2014","unstructured":"Kamdje AHN, Etet PFS, Vecchio L, Muller JM, Krampera M, Lukong KE. Signaling pathways in breast cancer: therapeutic targeting of the microenvironment. Cell Signal. 2014;26(12):2843\u201356. https:\/\/doi.org\/10.1016\/j.cellsig.2014.07.034.","journal-title":"Cell Signal"},{"issue":"6","key":"2889_CR48","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ctrv.2011.11.005","volume":"38","author":"P Eroles","year":"2012","unstructured":"Eroles P, Bosch A, P\u00e9rez-Fidalgo JA, Lluch A. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev. 2012;38(6):698\u2013707. https:\/\/doi.org\/10.1016\/j.ctrv.2011.11.005.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"2889_CR49","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/sj.bjc.6605365","volume":"101","author":"P Scriven","year":"2009","unstructured":"Scriven P, Coulson S, Haines R, Balasubramanian S, Cross S, Wyld L. Activation and clinical significance of the unfolded protein response in breast cancer. Br J Cancer. 2009;101(10):1692\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6605365.","journal-title":"Br J Cancer"},{"issue":"1","key":"2889_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-68454-9","volume":"10","author":"P Suman","year":"2020","unstructured":"Suman P, Mishra S, Chander H. High formin binding protein 17 (FBP17) expression indicates poor differentiation and invasiveness of ductal carcinomas. Sci Rep. 2020;10(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-020-68454-9.","journal-title":"Sci Rep"},{"issue":"6","key":"2889_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218030","volume":"14","author":"F Giudici","year":"2019","unstructured":"Giudici F, Petracci E, Nanni O, Bottin C, Pinamonti M, Zanconati F, et al. Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis. PLoS ONE. 2019;14(6): e0218030. https:\/\/doi.org\/10.1371\/journal.pone.0218030.","journal-title":"PLoS ONE"},{"issue":"11","key":"2889_CR52","doi-asserted-by":"publisher","first-page":"9397","DOI":"10.18632\/oncotarget.3351","volume":"6","author":"OL Cerqueira","year":"2015","unstructured":"Cerqueira OL, Truesdell P, Baldassarre T, Vilella-Arias SA, Watt K, Meens J, et al. CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis. Oncotarget. 2015;6(11):9397. https:\/\/doi.org\/10.18632\/oncotarget.3351.","journal-title":"Oncotarget"},{"issue":"19","key":"2889_CR53","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1056\/NEJM198811103191902","volume":"319","author":"MJ van de Vijver","year":"1988","unstructured":"van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, et al. Neu-protein overexpression in breast cancer. N Engl J Med. 1988;319(19):1239\u201345. https:\/\/doi.org\/10.1056\/NEJM198811103191902.","journal-title":"N Engl J Med"},{"issue":"9","key":"2889_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101503","volume":"23","author":"K Zhang","year":"2020","unstructured":"Zhang K, Liu H, Song Z, Jiang Y, Kim H, Samavati L, et al. The UPR Transducer IRE1 promotes breast cancer malignancy by degrading tumor suppressor microRNAs. Iscience. 2020;23(9): 101503. https:\/\/doi.org\/10.1016\/j.isci.2020.101503.","journal-title":"Iscience"},{"issue":"1","key":"2889_CR55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cellsig.2014.09.018","volume":"27","author":"H Li","year":"2015","unstructured":"Li H, Chen X, Gao Y, Wu J, Zeng F, Song F. XBP1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of breast cancer cells. Cell Signal. 2015;27(1):82\u20139. https:\/\/doi.org\/10.1016\/j.cellsig.2014.09.018.","journal-title":"Cell Signal"},{"issue":"6","key":"2889_CR56","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jclinpath-2012-201085","volume":"66","author":"N Pathmanathan","year":"2013","unstructured":"Pathmanathan N, Balleine RL. Ki67 and proliferation in breast cancer. J Clin Pathol. 2013;66(6):512\u20136. https:\/\/doi.org\/10.1136\/jclinpath-2012-201085.","journal-title":"J Clin Pathol"},{"issue":"7","key":"2889_CR57","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/jcp.2003.010777","volume":"57","author":"PJ van Diest","year":"2004","unstructured":"van Diest PJ, van der Wall E, Baak JP. Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol. 2004;57(7):675\u201381. https:\/\/doi.org\/10.1136\/jcp.2003.010777.","journal-title":"J Clin Pathol"},{"issue":"8","key":"2889_CR58","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/jcm8081092","volume":"8","author":"TS Gerashchenko","year":"2019","unstructured":"Gerashchenko TS, Novikov NM, Krakhmal NV, Zolotaryova SY, Zavyalova MV, Cherdyntseva NV, et al. Markers of cancer cell invasion: are they good enough? J Clin Med. 2019;8(8):1092. https:\/\/doi.org\/10.3390\/jcm8081092.","journal-title":"J Clin Med"},{"issue":"1","key":"2889_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-021-02328-w","volume":"19","author":"J Wu","year":"2021","unstructured":"Wu J, Wang X, Wang N, Ma L, Xie X, Zhang H, et al. Identification of novel antioxidant gene signature to predict the prognosis of patients with gastric cancer. World J Surg Oncol. 2021;19(1):1\u201311. https:\/\/doi.org\/10.1186\/s12957-021-02328-w.","journal-title":"World J Surg Oncol"},{"key":"2889_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17171","author":"R Xiao","year":"2022","unstructured":"Xiao R, Wang S, Guo J, Liu S, Ding A, Wang G, et al. Ferroptosis-related gene NOX4, CHAC1 and HIF1A are valid biomarkers for stomach adenocarcinoma. J Cell Mol Med. 2022. https:\/\/doi.org\/10.1111\/jcmm.17171.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2889_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08559-0","volume":"21","author":"Y Hong","year":"2021","unstructured":"Hong Y, Lin M, Ou D, Huang Z, Shen P. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma. BMC Cancer. 2021;21(1):1\u201314. https:\/\/doi.org\/10.1186\/s12885-021-08559-0.","journal-title":"BMC Cancer"},{"issue":"1","key":"2889_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08892-4","volume":"21","author":"W Tang","year":"2021","unstructured":"Tang W, Xu F, Zhao M, Zhang S. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer. BMC Cancer. 2021;21(1):1\u201319. https:\/\/doi.org\/10.1186\/s12885-021-08892-4.","journal-title":"BMC Cancer"},{"issue":"1","key":"2889_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-022-01194-z","volume":"15","author":"C Liu","year":"2022","unstructured":"Liu C, Liu Y, Yu Y, Zhao Y, Yu A. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma. BMC Med Genomics. 2022;15(1):1\u201317. https:\/\/doi.org\/10.1186\/s12920-022-01194-z.","journal-title":"BMC Med Genomics"},{"key":"2889_CR64","doi-asserted-by":"publisher","unstructured":"Xu Z, Xie Y, Mao Y, Huang J, Mei X, Song J et al. Ferroptosis-related gene signature predicts the prognosis of skin cutaneous melanoma and response to immunotherapy. Front Genet. 2021;12. doi:https:\/\/doi.org\/10.3389\/fgene.2021.758981.","DOI":"10.3389\/fgene.2021.758981"},{"issue":"12","key":"2889_CR65","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1039\/d0ob02259d","volume":"19","author":"J Nguyen","year":"2021","unstructured":"Nguyen J, Tirla A, Rivera-Fuentes P. Disruption of mitochondrial redox homeostasis by enzymatic activation of a trialkylphosphine probe. Org Biomol Chem. 2021;19(12):2681\u20137. https:\/\/doi.org\/10.1039\/d0ob02259d.","journal-title":"Org Biomol Chem"},{"issue":"5","key":"2889_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2021.8191","volume":"46","author":"Z Wang","year":"2021","unstructured":"Wang Z, Li M, Liu Y, Qiao Z, Bai T, Yang L, et al. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response-induced upregulation of CHAC1 expression. Oncol Rep. 2021;46(5):1\u201314. https:\/\/doi.org\/10.3892\/or.2021.8191.","journal-title":"Oncol Rep"},{"issue":"7","key":"2889_CR67","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1111\/jcmm.16458","volume":"25","author":"D Li","year":"2021","unstructured":"Li D, Liu S, Xu J, Chen L, Xu C, Chen F, et al. Ferroptosis-related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma. J Cell Mol Med. 2021;25(7):3610\u201321.","journal-title":"J Cell Mol Med"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-022-02889-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T17:06:14Z","timestamp":1665767174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-022-02889-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":67,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2889"],"URL":"https:\/\/doi.org\/10.1007\/s12094-022-02889-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The public database used in this study includes Kaplan\u2013Meier Plotter for CHAC1 transcripts (), cBioportal for correlation analysis between Ki67 and CHAC1 ().","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and materials"}},{"value":"No formal ethics approval was required for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to participate."}}]}}